About the NEI ORM

The NEI Office of Regenerative Medicine (ORM) provides scientific and administrative support to the vision research community. The ORM facilitates collaboration among scientists across the NIH and other federal agencies, academia, and nonprofit and private research sectors. ORM’s goal is to accelerate progress in regenerative medicine for vision.

The ORM helps coordinate the NEI Audacious Goals Initiative, the NEI 3-D Retina Organoid Challenge, the NIH Regenerative Medicine Innovation Project, and other activities.


calendar icon

May 3 to 7, 2020 |  ARVO Annual Meeting,

Baltimore, MD

calendar icon

October 2, 2020. Final deadline for 3-D ROC

calendar icon

October 24-28, 2020. Society for Neuroscience Annual Meeting. Washington, D.C.

ORM Contacts

Seven Baker Headshot

Amber Reed Headshot

Steven Becker, PhD

Associate Director

Amber Reed

Program Specialist


microscopy photo

NEI-Sponsored Initiatives

AGI - NEI Audacious Goals Initiative
NEI is pushing the boundaries of vision science. By facilitating cross-disciplinary research, the AGI is advancing regenerative medicine to tackle the most devastating and difficult-to-treat eye diseases.

3-D ROC - 3-D Retina Organoid Challenge
3-D ROC is spurring development of robust systems for modeling retinal diseases and testing new regenerative therapies.

Regenerative Medicine News

Potential Way to Halt Blinding Macular Degeneration Identified

January 22, 2020

Researchers at the University of Virginia have successfully treated age-related macular degeneration (AMD) in mice after finding an unexpected link between the two main forms of the blinding eye disease.

NIH, NIST researchers use artificial intelligence for quality control of stem cell-derived tissues

November 14, 2019

Researchers used artificial intelligence (AI) to evaluate stem cell-derived “patches” of retinal pigment epithelium (RPE) tissue for implanting into the eyes of patients with age-related macular degeneration (AMD), a leading cause of blindness.

Discovery in monkeys could lead to treatment for blindness causing syndrome

October 25, 2019

Oregon National Primate Research Center at OHSU reports first-ever nonhuman primate model for Bardet-Biedl Syndrome
Last updated: January 31, 2020